Los Angeles-based startup iCardio.ai has partnered with Abbott to develop AI applications for the company’s imaging devices used for treating patients with cardiac arrhythmias.
Specifically, iCardio.ai will support Abbott’s goals of automating model creations on the company’s EnSite X cardiac mapping system using 2D intracardiac echo images acquired by Abbott’s ICE catheters. Ensite X helps physicians visualize and position tools like the Abbott Volt pulsed field ablation catheter in the heart, which can lead to more accurate ablation procedures, it said.
